Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Bioenerg Biomembr ; 44(2): 273-80, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22437740

RESUMEN

2-Arachidonoylglicerol (2-AG) is an endocannabinoid that mimics the pharmacological effects of Δ9 tetrahydrocannabinol, the psychoactive component of the plant Cannabis sativa. It is present in many mammalian tissues, such as brain, liver, spleen, heart and kidney, where it exerts different biological effects either receptor mediated or independently of receptor activation. This work analyzes the effects of 2-AG on liver mitochondrial functions. It is shown that 2-AG causes a relevant decrease of calcium induced cyclosporine A sensitive cytochrome c release from mitochondria, a process representing an early event of the apoptotic program. Cyclosporin sensitive matrix swelling and ROS production measured under the same conditions are, on the contrary, almost unaffected or even enhanced, respectively, by 2-AG. Furthemore, 2-AG is found to stimulate resting state succinate oxidase activity and to inhibit oligomycin sensitive F0F1 ATP synthase activity. All these effects are apparently associated with 2-AG dependent alteration in the fluidity of the mitochondrial membranes, which was measured as generalized polarization of laurdan fluorescence.


Asunto(s)
Apoptosis/efectos de los fármacos , Calcio/metabolismo , Moduladores de Receptores de Cannabinoides/farmacología , Citocromos c/metabolismo , Endocannabinoides , Mitocondrias Hepáticas/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Animales , Ciclosporina/farmacología , Inmunosupresores/farmacología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA